Mon-Yee, M. orcid.org/0009-0001-6921-7529, Thokala, P., Lecky, F. orcid.org/0000-0001-6806-0921 et al. (3 more authors) (2026) Exploring the cost-effectiveness of blood biomarker tests to select patients with head injury and possible traumatic brain injury for CT brain scans in the UK setting. BMJ Open, 16 (11). e121486. ISSN: 2044-6055
Abstract
Background
Mild traumatic brain injury (mTBI) carries a risk of intracranial haemorrhage which may require observation, be prognostically significant, and in a small proportion of patients be life-threatening requiring urgent neurosurgical intervention. In the emergency department, a key component of the initial assessment is determining the need for a CT brain scan. An approach of providing CT scans to all patients is inefficient as more than 90% of CT scans performed for mTBI show no intracranial injury, and only 1%–2% result in neurosurgical intervention. However, delayed neurosurgery can result in avoidable deaths. Blood-based biomarker tests offer a potential solution by enabling improved risk stratification for CT imaging; however, their cost-effectiveness remains uncertain.
Objective
To evaluate the potential cost-effectiveness of blood biomarker tests for triaging patients with mTBI for further neuroimaging.
Design
Decision-analytic health economic modelling using parameter inputs based on data from a Collaborative European Neurotrauma Effectiveness Research mTBI (CENTER-TBI) cohort, published literature and clinical input. The model is composed of a 6-month decision tree followed by a lifetime state-transition model estimating health outcomes and costs based on whether treatment was prompt or delayed due to the diagnostic accuracy of the testing strategy. In the base case, all biomarker tests were assumed to have ≥95% sensitivity with specificity ranging from 8% to 42%; these data are derived from data from CENTER-TBI.
Setting
UK National Health Service.
Participants
Patients with mTBI who have been identified as needing a CT brain scan using UK National Institute for Health and Care Excellence Guidelines.
Interventions
‘CT all’ versus provision of CT only when blood biomarker result is positive.
Primary and secondary outcomes Incremental cost-effectiveness ratio, quality-adjusted life-years (QALYs) gained and costs valued at 2023/2024 prices.
Results
The base case model suggests that current biomarker tests generate less QALYs gained and incur higher costs compared with ‘CT all’ strategy. This is driven by the lower sensitivity of biomarkers, leading to more false negative cases, delayed treatment and QALY losses. This is coupled with the higher costs of treating false negative patients and in some patients incurring both the costs of biomarkers and CT scans. This finding is consistent across all scenarios.
Conclusions
Current biomarker tests are not estimated to be cost-effective in this setting compared with a ‘CT all’ strategy. However, should future biomarker tests achieve both a very high sensitivity and high specificity they could become a cost-effective alternative to CT scans for all.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. |
| Dates: |
|
| Institution: | The University of Sheffield |
| Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health |
| Date Deposited: | 17 Nov 2026 10:23 |
| Last Modified: | 17 Nov 2026 10:23 |
| Status: | Published |
| Publisher: | BMJ |
| Refereed: | Yes |
| Identification Number: | 10.1136/bmjopen-2026-121486 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:248029 |
Download
Filename: e121486.full.pdf
Licence: CC-BY 4.0

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)